AusCann Group Holdings Limited, an Australian cannabis company has started designing a clinical trial in which will test cannabis medicinal products on those with spinal injuries.
MedReleaf Australia has announced that it plans to make its medicinal cannabis products more accessible to Australians who are in a disadvantaged position, lowering some of their product costs.
The Green Organic Dutchman, whose headquarters are situated in Ontario, Canada, have just shipped over the first shipment of cannabis for the Australian medical cannabis market.
With CBD being approved by Australia’s regulatory system to be sold over the counter in pharmacies, many people are wondering how it works and whether there are any side effects to be advised of.
FreshLeaf Analytics, an industry consultancy says that cannabis could soon be on the mainstream market as more doctors and business are changing their attitudes towards CBD and medical cannabis.
ECS Botanics, a medical cannabis company in Australia has recorded its best ever quarter, generating around $900,000 last quarter, giving a 123% increase from the previous quarter.
Since being legalised in 2016, Australia has seen one of the biggest rises in medical cannabis prescriptions being approved by the Therapeutic Goods Administration’s Special Access Scheme.
Proposed laws in South Australia are said to be unfair to drivers, who could have their licence taken away after using prescribed medical cannabis. The same is not true for those taking opioids and other prescribed meds.
Findings by the University of South Australia found that whilst cannabis use in Australia rose across all states during the first lockdown, methamphetamine use dropped significantly.
As attitudes to cannabis gradually change throughout Australia, thousands of residents have signed a petition calling for the decimalisation of the drug. The petition calls for it to be downgraded to a Schedule 3 substance from a Schedule 8.
CBD oil has become popular around the world for its variety of medicinal side effects and therapies. But what exactly is this magical, therapeutic oil and is it yet legal within Australia?
What exactly is the Cannabis Entourage Effect, and how is Australian research and how this research could decide how the entourage effect can be used in pharmacies.
2021 will see more products being made available on the medicinal cannabis market withing Australia, with the medical sector leading the way for cannabis treatments.
Australian cannabis company Little Green Pharma (LGP) has received another large order for this year, to export medicinal cannabis products to Europe. The demand for cannabis exportation is growing rapidly.
In the US pets like dogs and cats are being treated with cannabis medication, for much the same reasons as humans, such as pain and seizures. But is Australia being slow on the uptake?
Dr Meghan Thomas explains why new research for medicinal cannabis is so important, what her role is with the medicinal cannabis industry and future research studies in development.
The Lambert Initiative for Cannabinoid Therapeutics and the Sydney Pharmacy School at the University of Sydney are surveying pharmacists to see if they are ready for medical cannabis prescriptions.
The latest budget from the Australian Federal Government contains $1.5 million for a trial looking in to personalised medicinal cannabis dosing in cancer patients.
Neurotech International Limited (ASX:NTI) is opening a clinical study trial in 20 children aged between 5-17 years, who have Autism Spectrum Disorder (ASD).
For the first time, a medicinal cannabis drug has been listed on the Australian Pharmaceutical Benefits Scheme (PBS). This means that those who suffer from dravet syndrome, a rare form of epilepsy, can get treatment.
The legislation around cannabis in Australia is slowly changing. Still, laws at the federal level and state level can be both inflicting and confusing. So, what are you allowed to do within Australia?
The first ever medicinal cannabis medication is soon to be on the Pharmaceutical Benefits Scheme, which will help with children suffering from a rare form of epilepsy (Dravet syndrome).
Medicinal cannabis on the Pharmaceutical Benefits Scheme (PBS) will be one of the debates at the Country Women’s Association (CWA) State Conference, which is held in Bega. The annual event will call for cannabis reform.
Views around cannabis, particularly in treating various ailments and disorders are rapidly changing. This article looks at what exactly medical cannabis is, what treatments are available within Australia and how they are taken.
Although the use of cannabis for medical reasons has been around for several years in Australia, how hard is it to get your hands on medicinal cannabis? This article looks at the laws within each Australian state.
This article from the Australian government site, explains the use of cannabis within the country, the trends of cannabis use, the drug’s effects, harms, treatment types, and the availability of medicinal cannabis medications.
At the moment the Australian government is not giving any clear indications as to whether Australia will legalise recreational cannabis. It is already legal in the ACT in small doses and attitudes are gradually changing.
Australian cannabis company Little Green Pharma is noticing a huge rise in people requesting medicinal cannabis medications. Investors have high hopes for shares as the demand for medical cannabis products keeps increasing.
A report, issued by FreshLeaf Analytics predicts the Australian cannabis industry will double by the end of next year. However if the industry is to generate more profits, it will need to make medical cannabis medications more accessible.
A cannabis company based in the town of Wonthaggi, in Victoria, has shipped its largest ever shipment of cannabis to Germany. The medications will help to treat patients suffering from cancer related symptoms, and chronic pain.
